Impaired insulin sensitivity [30,31], abnormal insulin production from pancreatic β-cell dysfunction [32,33], uncontrolled glucagon release [34], hypertriglyceridemia, and obesity all contribute to the risk for NODAT. This evidence concerns the gene INS and hypertriglyceridemia.